Evidence map›Paper›PMID 30250286›Full record

ArticleNature protocols2018

Acute and rapid degradation of endogenous proteins by Trim-Away.

Dean Clift, Chun So, William A McEwan, Leo C James, Melina Schuh

Erratum issuedOpen access · greenAbstract read
PubMed Publisher
In one paragraph

Article in Nature protocols, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 101 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
101citing papers in PubMed, 1 pooled it
5.0field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

101 citing papers in PubMed, 1 synthesis or guideline pooled it, 170 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Review
  6. Review
  7. Bridging maternal effects and epitranscriptomics: A novel perspective in developmental biology.Developmental dynamics : an official publication of the American Association of Anatomists · 2026
    Review
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. A cohesion optimum underlies chromosome segregation fidelity in oocytes.bioRxiv : the preprint server for biology · 2026
    Article
  17. Article
  18. Article
  19. Article
  20. Targeted Degradation of Mouse Embryo Proteins Using Trim-Away.Methods in molecular biology (Clifton, N.J.) · 2026
    Article

41 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 2 countries.

Dean CliftLaboratory of Molecular Biology, Medical Research Council, Cambridge, UK. dclift@mrc-lmb.cam.ac.uk.
Chun SoDepartment of Meiosis, Max Planck Institute for Biophysical Chemistry, Göttingen, Germany.
William A McEwanLaboratory of Molecular Biology, Medical Research Council, Cambridge, UK.
Leo C JamesLaboratory of Molecular Biology, Medical Research Council, Cambridge, UK. lcj@mrc-lmb.cam.ac.uk.
Melina SchuhLaboratory of Molecular Biology, Medical Research Council, Cambridge, UK. melina.schuh@mpibpc.mpg.de.
Max Planck Institute for Biophysical Chemistry · DEMedical Research Council · GBMRC Laboratory of Molecular Biology · GBUK Dementia Research Institute · GB

Funding

Medical Research Council MC_U105181010Medical Research Council MC_U105192711Wellcome Trust 200594/Z/16/Z
6 · The paper itself

Abstract

Protein depletion is a key approach to understanding the functions of a protein in a biological system. We recently developed the Trim-Away approach in order to rapidly degrade endogenous proteins without prior modification. Trim-Away is based on the ubiquitin ligase and Fc receptor TRIM21, which recognizes antibody-bound proteins and targets them for degradation by the proteasome. In a typical Trim-Away experiment, protein degradation is achieved in three steps: first, introduction of an antibody against the target protein; second, recruitment of endogenous or exogenous/overexpressed TRIM21 to the antibody-bound target protein; and third, proteasome-mediated degradation of the target protein, antibody and TRIM21 complex. Protein degradation by Trim-Away is acute and rapid, with half-lives of ~10-20 min. The major advantages of Trim-Away over other protein degradation methods are that it can be applied to any endogenous protein without prior modification; that it uses conventional antibodies that are widely available; and that it can be applied to a wide range of cell types, including nondividing primary human cells, for which other loss-of-function assays are challenging. In this protocol, we describe the detailed procedures for antibody preparation and delivery in mouse oocytes and cultured cells via microinjection and electroporation. In addition, we provide recommendations for antibody selection and validation, and for the generation of TRIM21-overexpressing cell lines for cases in which endogenous TRIM21 is limited. A typical Trim-Away experiment takes just a few hours.

Indexed as

ProteolysisAnimalsAntibodiesCell LineCells, CulturedElectroporationFemaleHumansMiceMicroinjectionsOocytesProteasome Endopeptidase ComplexProteinsRecombinant ProteinsRibonucleoproteinsSS-A AntigenAntibodiesProteasome Endopeptidase ComplexProteinsRecombinant ProteinsRibonucleoproteinsSS-A AntigenUbiquitinUbiquitin-Protein Ligases

Identifiers

PMID30250286
OpenAlexW2893792887

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.